Loading...

2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2025

June 23 - 25, 2025 | ExCeL London, UK

EP.0041

PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME (PCOS) IN TEENAGE GIRLS”

Part of Topic

Adolescent gynaecology

Prevalence Of Polycystic Ovarian Syndrome In Teenage Girls In a Tertiary Care Hospital In Islamabad, Pakistan

TehminaKanwal,Sadia Nazir,Qurat-ul-Ain,Naushin Farooq,Lubna Bashir,Sabeen Aslam

INTRODUCTION / BACKGROUND

 

•PCOS  most  frequent  reproductive endocrine  disorder  affecting reproductive  age  women.
•Diagnosing  PCOS  during teenage IS challenging  due to overlapping normal  pubertal  development  and typical features of PCOS.

Screening for PCOS in teenage girls is crucial as allows early intervention leading to better long-term reproductive and metabolic 

 

OBJECTIVES /AIMS

The  Objective  of  study is to assess  prevalence of polycystic ovarian syndrome  in teenage girls attending outpatient department of a tertiary care hospital Islamabad, Pakistan and advise early intervention on treatment of symptoms

                                                      MATERIAL & METHODS

 Study Design :  Cross- sectional study conducted at a tertiary care hospital in Islamabad

 Study duration :September 2023 – March 2024

 Sample size :105 teenage girls attending outpatient department.

 Sampling technique :Non- Probability convenient sampling

 Data was analyzed using SPSS 20.

CONCLUSION

 

Prevalence of “polycystic ovarian syndrome (PCOS)” among teenage girls of present study was 13 (12.38%) with significant impact of maternal PCOS history on prevalence of PCOS among teenage girls.

 

                                                                            RECOMMENDATION

Prevalence of PCOS is quite high and it is thus strongly recommended that regular screening for PCOS should be conducted in this particular age group so that timely intervention can be started to improve fertility and avoid potential complication associated with it, particularly the metabolic syndrome and cardiovascular events.

REFERENCES

 

Pea J, Bryan J, Wan C, Oldfield AL, Ganga K, Carter FE, et al. Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis. Hum Reprod Update. 2024;30(1):109-130. https://doi.org/10.1093/humupd/dmad027.

Ibrahim AA, Mohammed HS, Elsaid NMAB, Salim AA, Fathy EG, Hasaneen NM. Risk factors for polycystic ovary syndrome among women of reproductive age in Egypt: A case control study. Afr J Reprod Health. 2023;27(6):41-50. https://doi.org/10.29063/ajrh2023/v27i6.5.

Falcetta P, Benelli E, Molinaro A, Di Cosmo C, Bagattini B, Del Ghianda S, et al. Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome. J Endocrinol Invest. 2021;44(12):2725-2733. https://doi.org/10.1007/s40618-021-01594-5.

Akre S, Sharma K, Chakole S, Wanjari MB. Recent advances in the management of polycystic ovary syndrome: a review article. Cureus. 2022;14(8):e27689. https://doi.org/10.7759/cureus.27689.

Louwers YV, Laven JSE. Characteristics of polycystic ovary syndrome throughout life. Ther Adv Reprod Health. 2020;14:2633494120911038. https://doi.org/10.1177/2633494120911038.

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.